Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Claritin in Japan

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough's Japanese subsidiary will launch RediTabs imminently, the firm announces. The product is "the first and only allergy product in Japan designed to orally disintegrate," Schering says. The Rx drug's indications mirror those for use in the U.S. The Japanese Ministry of health cleared Claritin for prescription status in 2002 (1"The Tan Sheet" July 15, 2002, In Brief)...
Advertisement

Related Content

Generic Claritin-D

Topics

Advertisement
UsernamePublicRestriction

Register

PS097588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel